These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21897056)
1. Comparison of peripheral neuropathy induced by standard and nanoparticle albumin-bound paclitaxel in rats. Yamashita Y; Egashira N; Masuguchi K; Ushio S; Kawashiri T; Oishi R J Pharmacol Sci; 2011; 117(2):116-20. PubMed ID: 21897056 [TBL] [Abstract][Full Text] [Related]
2. Does nab-paclitaxel have a higher incidence of peripheral neuropathy than solvent-based paclitaxel? Evidence from a systematic review and meta-analysis. Guo X; Sun H; Dong J; Feng Y; Li H; Zhuang R; Wang P; Cai W; Zhou Y Crit Rev Oncol Hematol; 2019 Jul; 139():16-23. PubMed ID: 31112878 [TBL] [Abstract][Full Text] [Related]
3. Role of satellite cell-derived L-serine in the dorsal root ganglion in paclitaxel-induced painful peripheral neuropathy. Kiya T; Kawamata T; Namiki A; Yamakage M Neuroscience; 2011 Feb; 174():190-9. PubMed ID: 21118710 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: A prospective self-controlled trial. Kanbayashi Y; Sakaguchi K; Ishikawa T; Ouchi Y; Nakatsukasa K; Tabuchi Y; Kanehisa F; Hiramatsu M; Takagi R; Yokota I; Katoh N; Taguchi T Breast; 2020 Feb; 49():219-224. PubMed ID: 31901783 [TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of Gelsemium-based treatment against paclitaxel-induced painful symptoms. Vitet L; Patte-Mensah C; Boujedaini N; Mensah-Nyagan AG; Meyer L Neurol Sci; 2018 Dec; 39(12):2183-2196. PubMed ID: 30251080 [TBL] [Abstract][Full Text] [Related]
6. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial. Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157 [TBL] [Abstract][Full Text] [Related]
8. Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway. Sun H; Guo X; Wang Z; Wang P; Zhang Z; Dong J; Zhuang R; Zhou Y; Ma G; Cai W Oxid Med Cell Longev; 2019; 2019():3142732. PubMed ID: 30881589 [TBL] [Abstract][Full Text] [Related]
12. A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Polomano RC; Mannes AJ; Clark US; Bennett GJ Pain; 2001 Dec; 94(3):293-304. PubMed ID: 11731066 [TBL] [Abstract][Full Text] [Related]
13. Up-regulation of CX3CL1 via Nuclear Factor-κB-dependent Histone Acetylation Is Involved in Paclitaxel-induced Peripheral Neuropathy. Li D; Huang ZZ; Ling YZ; Wei JY; Cui Y; Zhang XZ; Zhu HQ; Xin WJ Anesthesiology; 2015 May; 122(5):1142-51. PubMed ID: 25494456 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications. Kudlowitz D; Muggia F Expert Opin Drug Saf; 2014 Jun; 13(6):681-5. PubMed ID: 24749649 [No Abstract] [Full Text] [Related]
15. Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study. Ko YJ; Canil CM; Mukherjee SD; Winquist E; Elser C; Eisen A; Reaume MN; Zhang L; Sridhar SS Lancet Oncol; 2013 Jul; 14(8):769-76. PubMed ID: 23706985 [TBL] [Abstract][Full Text] [Related]
16. A prospective comparison study utilizing patient-reported outcomes of taxane-related peripheral neuropathy between nab-paclitaxel and standard paclitaxel in patients with breast cancer. Kida K; Yamada A; Shimada K; Narui K; Sugae S; Shimizu D; Doi T; Oba M; Endo I; Ishikawa T Breast Cancer; 2024 May; 31(3):409-416. PubMed ID: 38453739 [TBL] [Abstract][Full Text] [Related]